Data for: Identification of protein biomarkers to differentiate between gram-negative and gram-positive infections in adult patients
https://doi.org/10.5878/5tfb-b833
Protein quantification conducted using Protein Extension Assay (PEA) at TATAA Biocenter, Gothenburg, Sweden following the manufacturer’s instructions. Four Olink biomarker panels— Cardiometabolic (v.3603), Cardiovascular II (v.5004), Immune Response (v.3202), and Inflammation (v.3021)— were employed to analyze proteins in the blood samples collected from 291 patients diagnosed with bacterial sepsis, including 184 with gram-negative and 107 with gram-positive bacterial sepsis, along with 40 healthy control individuals.
Files with open access (2)
Files with open access (2)
Citation and access
Citation and access
Access level:
Creator/Principal investigator(s):
Research principal:
Data contains personal data:
Yes
Type of personal data:
Pseudonymised health data contain indirect identifiers
Code key exists:
Yes
Sensitive personal data:
Yes
Citation:
Language:
Method and outcome
Method and outcome
Population:
Data and samples originated from a prospective observational study of community-onset severe sepsis and septic shock in adults conducted at Skaraborg Hospital, Sweden. The study was approved by the Regional Ethical Review Board of Gothenburg (376-11) and only included participants who gave their written informed consent.
The sampling for laboratory data was performed at the time of admission to the emergency department according to routine hospital procedures and prior to the administration of antibiotic therapy. To identify species type, microbiological culturing was performed as previously described. All medical records were retrospectively reviewed by two senior specialists in infectious diseases to determine whether the patients fulfilled Sepsis-3 criteria. Following the review, it was found that not all patients met the criteria for sepsis. According to Sepsis-3 criteria, bacterial sepsis was defined as bacterial infection-induced organ dysfunction characterized by a rise in total SOFA ≥2. Verified bacterial infection was defined as a clinical infection with identification of relevant bacteria by culture or typical clinical symptoms, such as erysipelas. The patients included in the current study were those with a verified bacterial infection. For protein quantification, blood samples were collected using sodium citrate tubes, and plasma was stored at -80 °C until subsequent analysis. The blood samples were collected from 291 patients diagnosed with bacterial sepsis, including 184 with gram-negative and 107 with gram-positive bacterial sepsis, along with 40 healthy control individuals.
Time period(s) investigated:
Geographic coverage
Geographic coverage
Geographic location:
Geographic description:
Skaraborg
Administrative information
Administrative information
Responsible department/unit:
School of Bioscience
Other research principals:
Contributor(s):
- Mahnaz Irani Shemirani – Göteborgs universitet
Ethical Review
Ethical Review
Reviewer:
- Göteborgs etikprövningsnämnd
Registration number:
376-11
Topic and keywords
Topic and keywords
Swedish Standard Classification of Research Subjects 2025:
Publications
Publications
Citation:
Shemirani, M. I.,Pernestig, A.-K., Björkman, J., Tilevik, D., von Mentzer, A., Ejdebäck, M., Ståhlberg, A. (2024). Identification of protein biomarkers to differentiate between gram-negative and gram-positive infections in adult patients, BMC Infectious Disease [Under Review]
Metadata
Metadata
Version 1

University of Skövde